We may, but the consensus among most researchers is several vaccines may be available in late Spring 2021, at the earliest. The FDA is allowing researchers to concomitantly perform Phase I, II, and III trials instead of completing each before moving to the next. However, these do take time, and the FDA must review the data before approval. And as I mentioned in my previous post, we currently don't have the manufacturing capabilities to produce the amount of vaccine needed. So that limited supply will be given to healthcare workers, and those at highest risk levels. General population availability will be much later.